Innoviva (INVA) Other Non-Current Liabilities (2014 - 2026)

Innoviva (INVA) reported Other Non-Current Liabilities of $1.1 million for Q1 2026, down 98.2% on a YoY basis from $62.0 million in Q1 2025, and little changed quarter-over-quarter from $1.1 million in Q4 2025.

Innoviva (INVA) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends

Innoviva has reported Other Non-Current Liabilities for 13 years, with the latest figure at $1.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Liabilities fell 98.2% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 98.2% YoY), and the FY2025 full-year result was $1.1 million, down 97.9% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $1.1 million, roughly flat from $1.1 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $78.4 million in Q3 2022, with the low at $1.1 million in Q3 2024.
  • Historically, Other Non-Current Liabilities has averaged $53.1 million across 5 years, with a median of $66.1 million in 2023.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities soared 560050.0% — and 2024, when it plunged 98.37%.
  • Innoviva's Other Non-Current Liabilities stood at $70.9 million in 2022, then decreased by 1.47% to $69.9 million in 2023, then decreased by 23.83% to $53.2 million in 2024, then sank by 97.9% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $56.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Innoviva 1.69 Bn 1.08 Bn 75.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.12 Mn
Dec 31, 2025 1.12 Mn
Sep 30, 2025 56.53 Mn
Jun 30, 2025 55.15 Mn
Mar 31, 2025 62.01 Mn
Dec 31, 2024 53.23 Mn
Sep 30, 2024 1.08 Mn
Jun 30, 2024 69.87 Mn
Mar 31, 2024 71.69 Mn
Dec 31, 2023 69.88 Mn
Sep 30, 2023 66.14 Mn
Jun 30, 2023 68.58 Mn
Mar 31, 2023 70.13 Mn
Dec 31, 2022 70.92 Mn
Sep 30, 2022 78.42 Mn
Sep 30, 2021 14,000.00
Jun 30, 2021 45,000.00
Mar 31, 2021 77,000.00
Dec 31, 2020 106,000.00
Sep 30, 2020 136,000.00